Table 3.
Follow-up outcomes in patients with bronchiectasis with and without PA
| Parameter | Whole group | PA | Non-PA | P values |
| Subject, n (%) | 899 | 183 (20.4) | 716 (79.6) | – |
| Person-years of observation | 3369 | 689.5 | 2679.5 | – |
| Mortality rate (deaths per person-year of observation) | 74/3369 | 22/689.5 | 52/2679.5 | 0.045 |
| Annual exacerbation frequency | 1.1 (1.2) | 1.8 (1.3) | 1.0 (1.1) | <0.001 |
| ΔmMRC score | 0.0 (1.0) | 0.2 (1.0) | −0.1 (0.9) | 0.001 |
| Δ LCQ score | 3.2 (2.7) | 2.7 (2.7) | 3.2 (2.7) | 0.033 |
| HADS score (anxiety) | 4.6 (2.3) | 4.9 (1.9) | 4.6 (2.4) | 0.005 |
| HADS score (depression) | 4.9 (2.2) | 5.6 (1.9) | 4.7 (2.3) | <0.001 |
Data are presented as n (%) or median (IQR), unless otherwise stated.
HADS, Hospital Anxiety and Depression Scale; ΔLCQ, the difference between follow-up and initial LCQ values; ΔmMRC, the difference between follow-up and initial mMRC values; mMRC, modified Medical Research Council; PA, Pseudomonas aeruginosa.